Peruvian Institutes Partner to Develop Radiation-Sterilized Tissues for Severe Burns and Cancer Patients
The Peruvian Institute of Nuclear Energy (IPEN) and the National Institute of Children's Health of San Borja (INSNSB) have signed an agreement to advance new treatments for patients with complex conditions like severe burns and cancer. This collaboration aims to integrate IPEN's nuclear technology with INSNSB's clinical expertise for the research and production of various biological materials, including cells, biomaterials, biological matrices, polymer matrices, and radiation-sterilized tissues. These products are intended for patients suffering from severe burns, critical traumatic injuries, cancer, and will also support ophthalmological and periodontal surgeries. The two institutions have a history of successful joint projects, notably the irradiation of pig skin used as a temporary biological dressing for severe burn victims after the 2001 Mesa Redonda fire. They also collaborated on establishing the INSNSB Tissue Bank. IPEN President Carlos Felipe Palomares Villanueva highlighted that this renewed cooperation will foster new research, boost national technological development, and improve patient access to safe, innovative, and impactful therapies. Zulema Tomas Gonzales, Director General of INSNSB, emphasized that this partnership directly benefits children with severe burns and cancer, acknowledging IPEN as Peru's sole Tissue Bank that has been instrumental in saving the lives of children with extensive burns since 2016. The International Atomic Energy Agency (IAEA) has recognized the joint efforts of IPEN and INSNSB, particularly their success in treating children with severe burns.
This collaboration exemplifies the application of nuclear technology for humanitarian purposes, shifting the perception of nuclear energy from destructive potential to life-saving applications in medicine. By combining IPEN's radiation sterilization capabilities with INSNSB's pediatric medical expertise, Peru is developing domestic capacity for advanced biomaterials. This initiative addresses critical healthcare needs, particularly for burn and cancer patients, potentially reducing reliance on imported medical supplies and fostering national self-sufficiency in specialized treatments. The long-term success hinges on sustained funding, regulatory oversight, and equitable access to these advanced therapies, ensuring that technological progress translates into tangible public health benefits for vulnerable populations.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.